Global Orphan Drugs for Adults Market Research Report 2023

Orphan Drugs for Adults Market

Orphan drugs for adults refer to medications that are specifically developed and approved for the treatment of rare diseases or conditions in adult populations. These drugs are designed to address medical needs in adult patients who have limited treatment options due to the rarity of their conditions.

Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Orphan Drugs for Adults market research.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Orphan Drugs for Adults market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Orphan Drugs for Adults Market Report

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Orphan Drugs for Adults Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Oncology Drugs

1.2.3 Gastrointestinal Drugs

1.2.4 Neurology Drugs

1.2.5 Cardio-vascular Drugs

1.2.6 Others

1.3 Market by Application

1.3.1 Global Orphan Drugs for Adults Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospital Pharmacies

1.3.3 Retail pharmacies

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Orphan Drugs for Adults Market Perspective (2018-2029)

2.2 Orphan Drugs for Adults Growth Trends by Region

2.2.1 Global Orphan Drugs for Adults Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Orphan Drugs for Adults Historic Market Size by Region (2018-2023)

2.2.3 Orphan Drugs for Adults Forecasted Market Size by Region (2024-2029)

2.3 Orphan Drugs for Adults Market Dynamics

2.3.1 Orphan Drugs for Adults Industry Trends

2.3.2 Orphan Drugs for Adults Market Drivers

2.3.3 Orphan Drugs for Adults Market Challenges

2.3.4 Orphan Drugs for Adults Market Restraints

3.1 Global Top Orphan Drugs for Adults Players by Revenue

3.1.1 Global Top Orphan Drugs for Adults Players by Revenue (2018-2023)

3.1.2 Global Orphan Drugs for Adults Revenue Market Share by Players (2018-2023)

3.2 Global Orphan Drugs for Adults Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Orphan Drugs for Adults Revenue

3.4 Global Orphan Drugs for Adults Market Concentration Ratio

3.4.1 Global Orphan Drugs for Adults Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Orphan Drugs for Adults Revenue in 2022

3.5 Orphan Drugs for Adults Key Players Head office and Area Served

3.6 Key Players Orphan Drugs for Adults Product Solution and Service

3.7 Date of Enter into Orphan Drugs for Adults Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Orphan Drugs for Adults Historic Market Size by Type (2018-2023)

4.2 Global Orphan Drugs for Adults Forecasted Market Size by Type (2024-2029)

5.1 Global Orphan Drugs for Adults Historic Market Size by Application (2018-2023)

5.2 Global Orphan Drugs for Adults Forecasted Market Size by Application (2024-2029)

6.1 North America Orphan Drugs for Adults Market Size (2018-2029)

6.2 North America Orphan Drugs for Adults Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Orphan Drugs for Adults Market Size by Country (2018-2023)

6.4 North America Orphan Drugs for Adults Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Orphan Drugs for Adults Market Size (2018-2029)

7.2 Europe Orphan Drugs for Adults Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Orphan Drugs for Adults Market Size by Country (2018-2023)

7.4 Europe Orphan Drugs for Adults Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Orphan Drugs for Adults Market Size (2018-2029)

8.2 Asia-Pacific Orphan Drugs for Adults Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Orphan Drugs for Adults Market Size by Region (2018-2023)

8.4 Asia-Pacific Orphan Drugs for Adults Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Orphan Drugs for Adults Market Size (2018-2029)

9.2 Latin America Orphan Drugs for Adults Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Orphan Drugs for Adults Market Size by Country (2018-2023)

9.4 Latin America Orphan Drugs for Adults Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Orphan Drugs for Adults Market Size (2018-2029)

10.2 Middle East & Africa Orphan Drugs for Adults Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Orphan Drugs for Adults Market Size by Country (2018-2023)

10.4 Middle East & Africa Orphan Drugs for Adults Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Abbvie

11.1.1 Abbvie Company Detail

11.1.2 Abbvie Business Overview

11.1.3 Abbvie Orphan Drugs for Adults Introduction

11.1.4 Abbvie Revenue in Orphan Drugs for Adults Business (2018-2023)

11.1.5 Abbvie Recent Development

11.2 Orpharma

11.2.1 Orpharma Company Detail

11.2.2 Orpharma Business Overview

11.2.3 Orpharma Orphan Drugs for Adults Introduction

11.2.4 Orpharma Revenue in Orphan Drugs for Adults Business (2018-2023)

11.2.5 Orpharma Recent Development

11.3 Amgen

11.3.1 Amgen Company Detail

11.3.2 Amgen Business Overview

11.3.3 Amgen Orphan Drugs for Adults Introduction

11.3.4 Amgen Revenue in Orphan Drugs for Adults Business (2018-2023)

11.3.5 Amgen Recent Development

11.4 Recordati

11.4.1 Recordati Company Detail

11.4.2 Recordati Business Overview

11.4.3 Recordati Orphan Drugs for Adults Introduction

11.4.4 Recordati Revenue in Orphan Drugs for Adults Business (2018-2023)

11.4.5 Recordati Recent Development

11.5 Novartis

11.5.1 Novartis Company Detail

11.5.2 Novartis Business Overview

11.5.3 Novartis Orphan Drugs for Adults Introduction

11.5.4 Novartis Revenue in Orphan Drugs for Adults Business (2018-2023)

11.5.5 Novartis Recent Development

11.6 Celgene

11.6.1 Celgene Company Detail

11.6.2 Celgene Business Overview

11.6.3 Celgene Orphan Drugs for Adults Introduction

11.6.4 Celgene Revenue in Orphan Drugs for Adults Business (2018-2023)

11.6.5 Celgene Recent Development

11.7 Amryt Pharma

11.7.1 Amryt Pharma Company Detail

11.7.2 Amryt Pharma Business Overview

11.7.3 Amryt Pharma Orphan Drugs for Adults Introduction

11.7.4 Amryt Pharma Revenue in Orphan Drugs for Adults Business (2018-2023)

11.7.5 Amryt Pharma Recent Development

11.8 Johnson & Johnson

11.8.1 Johnson & Johnson Company Detail

11.8.2 Johnson & Johnson Business Overview

11.8.3 Johnson & Johnson Orphan Drugs for Adults Introduction

11.8.4 Johnson & Johnson Revenue in Orphan Drugs for Adults Business (2018-2023)

11.8.5 Johnson & Johnson Recent Development

11.9 GSK

11.9.1 GSK Company Detail

11.9.2 GSK Business Overview

11.9.3 GSK Orphan Drugs for Adults Introduction

11.9.4 GSK Revenue in Orphan Drugs for Adults Business (2018-2023)

11.9.5 GSK Recent Development

11.10 Bristol-Myers Squibb Company

11.10.1 Bristol-Myers Squibb Company Company Detail

11.10.2 Bristol-Myers Squibb Company Business Overview

11.10.3 Bristol-Myers Squibb Company Orphan Drugs for Adults Introduction

11.10.4 Bristol-Myers Squibb Company Revenue in Orphan Drugs for Adults Business (2018-2023)

11.10.5 Bristol-Myers Squibb Company Recent Development

11.11 Roche Holding

11.11.1 Roche Holding Company Detail

11.11.2 Roche Holding Business Overview

11.11.3 Roche Holding Orphan Drugs for Adults Introduction

11.11.4 Roche Holding Revenue in Orphan Drugs for Adults Business (2018-2023)

11.11.5 Roche Holding Recent Development

11.12 Sanofi

11.12.1 Sanofi Company Detail

11.12.2 Sanofi Business Overview

11.12.3 Sanofi Orphan Drugs for Adults Introduction

11.12.4 Sanofi Revenue in Orphan Drugs for Adults Business (2018-2023)

11.12.5 Sanofi Recent Development

11.13 Takeda

11.13.1 Takeda Company Detail

11.13.2 Takeda Business Overview

11.13.3 Takeda Orphan Drugs for Adults Introduction

11.13.4 Takeda Revenue in Orphan Drugs for Adults Business (2018-2023)

11.13.5 Takeda Recent Development

11.14 Pfizer

11.14.1 Pfizer Company Detail

11.14.2 Pfizer Business Overview

11.14.3 Pfizer Orphan Drugs for Adults Introduction

11.14.4 Pfizer Revenue in Orphan Drugs for Adults Business (2018-2023)

11.14.5 Pfizer Recent Development

11.15 Vertex Pharmaceuticals

11.15.1 Vertex Pharmaceuticals Company Detail

11.15.2 Vertex Pharmaceuticals Business Overview

11.15.3 Vertex Pharmaceuticals Orphan Drugs for Adults Introduction

11.15.4 Vertex Pharmaceuticals Revenue in Orphan Drugs for Adults Business (2018-2023)

11.15.5 Vertex Pharmaceuticals Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Orphan Drugs for Adults Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Oncology Drugs

    Table 3. Key Players of Gastrointestinal Drugs

    Table 4. Key Players of Neurology Drugs

    Table 5. Key Players of Cardio-vascular Drugs

    Table 6. Key Players of Others

    Table 7. Global Orphan Drugs for Adults Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Orphan Drugs for Adults Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 9. Global Orphan Drugs for Adults Market Size by Region (2018-2023) & (US$ Million)

    Table 10. Global Orphan Drugs for Adults Market Share by Region (2018-2023)

    Table 11. Global Orphan Drugs for Adults Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 12. Global Orphan Drugs for Adults Market Share by Region (2024-2029)

    Table 13. Orphan Drugs for Adults Market Trends

    Table 14. Orphan Drugs for Adults Market Drivers

    Table 15. Orphan Drugs for Adults Market Challenges

    Table 16. Orphan Drugs for Adults Market Restraints

    Table 17. Global Orphan Drugs for Adults Revenue by Players (2018-2023) & (US$ Million)

    Table 18. Global Orphan Drugs for Adults Market Share by Players (2018-2023)

    Table 19. Global Top Orphan Drugs for Adults Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orphan Drugs for Adults as of 2022)

    Table 20. Ranking of Global Top Orphan Drugs for Adults Companies by Revenue (US$ Million) in 2022

    Table 21. Global 5 Largest Players Market Share by Orphan Drugs for Adults Revenue (CR5 and HHI) & (2018-2023)

    Table 22. Key Players Headquarters and Area Served

    Table 23. Key Players Orphan Drugs for Adults Product Solution and Service

    Table 24. Date of Enter into Orphan Drugs for Adults Market

    Table 25. Mergers & Acquisitions, Expansion Plans

    Table 26. Global Orphan Drugs for Adults Market Size by Type (2018-2023) & (US$ Million)

    Table 27. Global Orphan Drugs for Adults Revenue Market Share by Type (2018-2023)

    Table 28. Global Orphan Drugs for Adults Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 29. Global Orphan Drugs for Adults Revenue Market Share by Type (2024-2029)

    Table 30. Global Orphan Drugs for Adults Market Size by Application (2018-2023) & (US$ Million)

    Table 31. Global Orphan Drugs for Adults Revenue Market Share by Application (2018-2023)

    Table 32. Global Orphan Drugs for Adults Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 33. Global Orphan Drugs for Adults Revenue Market Share by Application (2024-2029)

    Table 34. North America Orphan Drugs for Adults Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. North America Orphan Drugs for Adults Market Size by Country (2018-2023) & (US$ Million)

    Table 36. North America Orphan Drugs for Adults Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Europe Orphan Drugs for Adults Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Europe Orphan Drugs for Adults Market Size by Country (2018-2023) & (US$ Million)

    Table 39. Europe Orphan Drugs for Adults Market Size by Country (2024-2029) & (US$ Million)

    Table 40. Asia-Pacific Orphan Drugs for Adults Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Asia-Pacific Orphan Drugs for Adults Market Size by Region (2018-2023) & (US$ Million)

    Table 42. Asia-Pacific Orphan Drugs for Adults Market Size by Region (2024-2029) & (US$ Million)

    Table 43. Latin America Orphan Drugs for Adults Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Latin America Orphan Drugs for Adults Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Latin America Orphan Drugs for Adults Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Middle East & Africa Orphan Drugs for Adults Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 47. Middle East & Africa Orphan Drugs for Adults Market Size by Country (2018-2023) & (US$ Million)

    Table 48. Middle East & Africa Orphan Drugs for Adults Market Size by Country (2024-2029) & (US$ Million)

    Table 49. Abbvie Company Detail

    Table 50. Abbvie Business Overview

    Table 51. Abbvie Orphan Drugs for Adults Product

    Table 52. Abbvie Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)

    Table 53. Abbvie Recent Development

    Table 54. Orpharma Company Detail

    Table 55. Orpharma Business Overview

    Table 56. Orpharma Orphan Drugs for Adults Product

    Table 57. Orpharma Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)

    Table 58. Orpharma Recent Development

    Table 59. Amgen Company Detail

    Table 60. Amgen Business Overview

    Table 61. Amgen Orphan Drugs for Adults Product

    Table 62. Amgen Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)

    Table 63. Amgen Recent Development

    Table 64. Recordati Company Detail

    Table 65. Recordati Business Overview

    Table 66. Recordati Orphan Drugs for Adults Product

    Table 67. Recordati Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)

    Table 68. Recordati Recent Development

    Table 69. Novartis Company Detail

    Table 70. Novartis Business Overview

    Table 71. Novartis Orphan Drugs for Adults Product

    Table 72. Novartis Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)

    Table 73. Novartis Recent Development

    Table 74. Celgene Company Detail

    Table 75. Celgene Business Overview

    Table 76. Celgene Orphan Drugs for Adults Product

    Table 77. Celgene Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)

    Table 78. Celgene Recent Development

    Table 79. Amryt Pharma Company Detail

    Table 80. Amryt Pharma Business Overview

    Table 81. Amryt Pharma Orphan Drugs for Adults Product

    Table 82. Amryt Pharma Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)

    Table 83. Amryt Pharma Recent Development

    Table 84. Johnson & Johnson Company Detail

    Table 85. Johnson & Johnson Business Overview

    Table 86. Johnson & Johnson Orphan Drugs for Adults Product

    Table 87. Johnson & Johnson Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)

    Table 88. Johnson & Johnson Recent Development

    Table 89. GSK Company Detail

    Table 90. GSK Business Overview

    Table 91. GSK Orphan Drugs for Adults Product

    Table 92. GSK Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)

    Table 93. GSK Recent Development

    Table 94. Bristol-Myers Squibb Company Company Detail

    Table 95. Bristol-Myers Squibb Company Business Overview

    Table 96. Bristol-Myers Squibb Company Orphan Drugs for Adults Product

    Table 97. Bristol-Myers Squibb Company Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)

    Table 98. Bristol-Myers Squibb Company Recent Development

    Table 99. Roche Holding Company Detail

    Table 100. Roche Holding Business Overview

    Table 101. Roche Holding Orphan Drugs for Adults Product

    Table 102. Roche Holding Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)

    Table 103. Roche Holding Recent Development

    Table 104. Sanofi Company Detail

    Table 105. Sanofi Business Overview

    Table 106. Sanofi Orphan Drugs for Adults Product

    Table 107. Sanofi Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)

    Table 108. Sanofi Recent Development

    Table 109. Takeda Company Detail

    Table 110. Takeda Business Overview

    Table 111. Takeda Orphan Drugs for Adults Product

    Table 112. Takeda Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)

    Table 113. Takeda Recent Development

    Table 114. Pfizer Company Detail

    Table 115. Pfizer Business Overview

    Table 116. Pfizer Orphan Drugs for Adults Product

    Table 117. Pfizer Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)

    Table 118. Pfizer Recent Development

    Table 119. Vertex Pharmaceuticals Company Detail

    Table 120. Vertex Pharmaceuticals Business Overview

    Table 121. Vertex Pharmaceuticals Orphan Drugs for Adults Product

    Table 122. Vertex Pharmaceuticals Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)

    Table 123. Vertex Pharmaceuticals Recent Development

    Table 124. Research Programs/Design for This Report

    Table 125. Key Data Information from Secondary Sources

    Table 126. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Orphan Drugs for Adults Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Orphan Drugs for Adults Market Share by Type: 2022 VS 2029

    Figure 3. Oncology Drugs Features

    Figure 4. Gastrointestinal Drugs Features

    Figure 5. Neurology Drugs Features

    Figure 6. Cardio-vascular Drugs Features

    Figure 7. Others Features

    Figure 8. Global Orphan Drugs for Adults Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 9. Global Orphan Drugs for Adults Market Share by Application: 2022 VS 2029

    Figure 10. Hospital Pharmacies Case Studies

    Figure 11. Retail pharmacies Case Studies

    Figure 12. Others Case Studies

    Figure 13. Orphan Drugs for Adults Report Years Considered

    Figure 14. Global Orphan Drugs for Adults Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 15. Global Orphan Drugs for Adults Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 16. Global Orphan Drugs for Adults Market Share by Region: 2022 VS 2029

    Figure 17. Global Orphan Drugs for Adults Market Share by Players in 2022

    Figure 18. Global Top Orphan Drugs for Adults Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orphan Drugs for Adults as of 2022)

    Figure 19. The Top 10 and 5 Players Market Share by Orphan Drugs for Adults Revenue in 2022

    Figure 20. North America Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. North America Orphan Drugs for Adults Market Share by Country (2018-2029)

    Figure 22. United States Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Canada Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Orphan Drugs for Adults Market Share by Country (2018-2029)

    Figure 26. Germany Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. France Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. U.K. Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Italy Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Russia Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Nordic Countries Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Orphan Drugs for Adults Market Share by Region (2018-2029)

    Figure 34. China Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Japan Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. South Korea Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Southeast Asia Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. India Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Australia Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Orphan Drugs for Adults Market Share by Country (2018-2029)

    Figure 42. Mexico Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Brazil Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Orphan Drugs for Adults Market Share by Country (2018-2029)

    Figure 46. Turkey Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Saudi Arabia Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Abbvie Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)

    Figure 49. Orpharma Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)

    Figure 50. Amgen Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)

    Figure 51. Recordati Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)

    Figure 52. Novartis Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)

    Figure 53. Celgene Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)

    Figure 54. Amryt Pharma Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)

    Figure 55. Johnson & Johnson Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)

    Figure 56. GSK Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)

    Figure 57. Bristol-Myers Squibb Company Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)

    Figure 58. Roche Holding Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)

    Figure 59. Sanofi Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)

    Figure 60. Takeda Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)

    Figure 61. Pfizer Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)

    Figure 62. Vertex Pharmaceuticals Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)

    Figure 63. Bottom-up and Top-down Approaches for This Report

    Figure 64. Data Triangulation

    Figure 65. Key Executives Interviewed